Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis

Pneumocystis jiroveci pneumonia (PCP) is frequently reported in lymphoma patients treated with rituximab-contained regimens. There is a trend toward a difference in PCP risk between bi- and tri-weekly regimens. The aims of this systemic review and meta-analysis were to estimate the risk for PCP in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xuqin, Mei, Xiaodong, Feng, Di, Wang, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409297/
https://www.ncbi.nlm.nih.gov/pubmed/25909634
http://dx.doi.org/10.1371/journal.pone.0122171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409297/
https://www.ncbi.nlm.nih.gov/pubmed/25909634
http://dx.doi.org/10.1371/journal.pone.0122171

Ejemplares similares